Creighton University

Creighton University, a private Jesuit research institution based in Omaha, Nebraska, serves federal agencies as a recipient of educational service contracts and research and training grants, competing in full-and-open procurements without set-aside designations. The university operates as a tax-exempt nonprofit educational institution across 626 prime and sub awards spanning health sciences education, biomedical research, and student support programming.

Creighton's federal footprint centers on tuition and educational services to military personnel and biomedical research training. On the contract side, the university delivers military medical education and tuition assistance through recurring delivery orders under Navy Bureau of Medicine and Surgery indefinite delivery contracts, with recent awards including $153,680 for fall-term tuition (August–December 2026), $339,792 for spring-term tuition (January–May 2026), and $294,759 for fall-term tuition (May–December 2025). The Navy's IDC N0018907GZ038 accounts for 83 task orders totaling $15.3 million in combined potential value. On the grant side, Creighton holds a robust portfolio of NIH-funded biomedical research awards alongside NSF, Department of Education, and Department of Defense research and training grants, with recent recipients awards including a $399,454 National Science Foundation grant (CFDA 47.076) to develop sustainable open-source software frameworks in service-learning contexts (October 2026–September 2029), a $350,000 National Eye Institute award (CFDA 93.859) for discovery of trifunctional hybrid compounds for glaucoma therapy (September 2026–July 2031), and a $497,267 National Institute of Neurological Disorders and Stroke award (CFDA 93.853) investigating autoresuscitation failure in sudden unexpected death in epilepsy (September 2026–August 2031). The university also holds a $1,450,000 Department of Education award (CFDA 84.116) to deploy virtual reality and engaging technologies for healthcare delivery (September 2024–August 2027).

Customer concentration is split between military-medical and research-focused agencies. The Department of Veterans Affairs Veterans Integrated Service Network 23 leads by potential value at $23.7 million across 44 awards, followed by the Navy Bureau of Medicine and Surgery at $14.2 million across 84 awards. The National Institutes of Health portfolio spans 63 awards across multiple component institutes, with work concentrated in sensory neuroscience, infectious disease, cancer biology, and developmental disorders. Creighton competes predominantly in full-and-open, non-set-aside procurements across all customer agencies.

Creighton holds a single-award Basic Ordering Agreement with the Navy Bureau of Medicine and Surgery (established February 20, 2026, extending through February 19, 2036) supporting tuition and educational services. The university also placed task orders under Army Basic Ordering Agreements (DAKF5775H0460, with 21 task orders) and multiple Navy and Air Force vehicles (N0060084G5958, F3360076A0245, N0060085G1809, each with 8 to 9 task orders).

In its sub-recipient role, Creighton contributes to larger research efforts led by the University of Nebraska Board of Regents (Nebraska Research Network in Functional Genomics, multiple sub-awards), Colorado State University (prion strain pathogenesis and alpha-synuclein research), Johns Hopkins University (STEMM opportunities for college students with hearing loss), Father Flanagan's Boys' Home (pediatric cerebral palsy neurophysiology and intervention studies), and University of Washington (vestibular hair cell research). Creighton faculty serve as co-investigators and clinical expertise contributors on NIH-funded grants, with researchers specializing in auditory and vestibular neuroscience, prion disease, pediatric rehabilitation, and immunology.

Activity has grown modestly—from 23 awards in 2022 to 38 in 2024, with 21 awards each in 2025 and 2026. Twenty-five awards face ultimate completion within the next twenty-four months, carrying combined potential value of $560 thousand and representing recompete risk on Navy and VA tuition contracts and several small NSF research grants. The university's primary capability framing centers on STEM and health professions education delivery to federal agencies and biomedical research training across NIH institutes, with particular depth in auditory and vestibular neuroscience, epilepsy, infectious disease, and cancer biology research.